Multidrug therapy for leprosy in Trinidad and Tobago: a preliminary report.
D000072:Acedapsone / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D002991:Clofazimine / Q000627:therapeutic use*; D003622:Dapsone / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use*; D014300:Trinidad and Tobago
D000072:Acedapsone; D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin